| Ticker Details |
Myomo Inc.
Myomo Inc is a medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line of lightweight, non-invasive, powered arm braces.
|
| IPO Date: |
June 12, 2017 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$68.52M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.20 | 4.87%
|
| Avg Daily Range (30 D): |
$0.08 | 6.21%
|
| Avg Daily Range (90 D): |
$0.07 | 5.79%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.43M |
| Avg Daily Volume (30 D): |
.52M |
| Avg Daily Volume (90 D): |
.63M |
| Trade Size |
| Avg Trade Size (Sh.): |
248 |
| Avg Trade Size (Sh.) (30 D): |
173 |
| Avg Trade Size (Sh.) (90 D): |
199 |
| Institutional Trades |
| Total Institutional Trades: |
13 |
| Avg Institutional Trade: |
$1.41M |
| Avg Institutional Trade (30 D): |
$3.43M |
| Avg Institutional Trade (90 D): |
$2.04M |
| Avg Institutional Trade Volume: |
.65M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.88M |
| Avg Closing Trade (30 D): |
$3.43M |
| Avg Closing Trade (90 D): |
$2.04M |
| Avg Closing Volume: |
975.84K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-.34
|
$-.09
|
$-.07
|
|
Diluted EPS
|
$-.34
|
$-.09
|
$-.07
|
|
Revenue
|
$43.26M
|
$11.7M
|
$10.11M
|
|
Gross Profit
|
$29.57M
|
$8.44M
|
$6.9M
|
|
Net Income / Loss
|
$-14.51M
|
$-4.02M
|
$-3.01M
|
|
Operating Income / Loss
|
$-11.7M
|
$-2.25M
|
$-3.16M
|
|
Cost of Revenue
|
$13.69M
|
$3.26M
|
$3.21M
|
|
Net Cash Flow
|
$-2.77M
|
$-2.86M
|
$M
|
|
PE Ratio
|
|
|
|
|
|
|